Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Authors of Comment discuss clinical outcomes of corticosteroid(CS) use in coronavirus and similar outbreaks. They conclude no unique reason exists to expect patients with 2019-nCoV induced lung injury or shock will benefit from CSs, and harm may be more likely with such treatment


The Lancet